![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/1902-1590409416.jpg\")
<\/p>\n<\/p>\n
According to the new market research report“<\/strong>Risk-based Monitoring Software Marketby End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) – Global Forecast to 2025<\/strong>“,<\/strong>published by MarketsandMarkets Download PDF Brochure:<\/strong> The key factors driving the growth of this market are the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials.<\/p>\n By type, the Enterprise RBM Software segment is expected to account for the largest share of the<\/strong>Risk-based Monitoring Software Market<\/strong>in 2020<\/strong><\/p>\n Based on type, the market is segmented into Enterprise RBM Software and Site RBM Software. In 2020, the Enterprise RBM Software segment is expected to command the largest share of the market. The large share of this segment can be attributed to the widespread adoption of enterprise RBM software by end-users as it allows all authorized professionals to have access to clinical trial data and metrics placed at a centralized location.<\/p>\n By component, the software segment is expected to account for the largest share of the RBM software market in 2020<\/strong><\/p>\n Based on the component, the market is segmented into Software and Services. In 2020, the software segment is expected to command the largest share of the market. The large share of this segment can be attributed to the increasing R&D expenditure in the life science and clinical research industries, increasing number of clinical trials, and rising customer base.<\/p>\n Browsein-depth TOC on<\/em>“<\/strong>Risk-based Monitoring Software Market<\/a>“<\/strong><\/p>\n 114 – Tables By delivery mode, the delivery mode segment is expected to account for the largest share of the RBM software market in 2020<\/strong><\/p>\n Based on delivery mode, the market is segmented into Web-based (On-demand), Licensed Enterprise (On-premise), and Cloud-based (SaaS). In 2020, the Web-based (On-demand) segment is expected to command the largest share of the market. The large share of this segment can be attributed to the advantages offered by web-based software, such as easy access, improved productivity, time efficiency, and cost-efficiency.<\/p>\n By end-user, the pharmaceutical and biopharmaceutical companies<\/strong>end-user segment is expected to account for the largest share of the Risk-based Monitoring Software Market in 2020<\/strong><\/p>\n Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, CROs, medical device companies, and other end users. In 2020, the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.<\/p>\n North America<\/span>to dominate the market in 2020<\/strong><\/p>\n North America<\/span>,Europe<\/span>,Asia Pacific<\/span>, and the Rest of the World (RoW) are the regions considered for geographic analysis of the globalRisk-based Monitoring Software Market<\/strong><\/strong>study.North America<\/span>is expected to account for the largest share of the global market. The large share ofNorth America<\/span>is attributed to the to the increased adoption of RBM software solutions for clinical trials.<\/p>\n The prominent players in the global RBM software market include Oracle (US), Medidata Solutions (US), and Parexel (US). Other prominent players in the market are Bioclinica (US), Bio-Optronics (US), IBM Corporation (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), Anju Software (US), MaxisIT (US), Techsol Corporation (US), OpenClinica (US), CRF Health (US), and Covance (US).<\/p>\n Tags: <\/a>, Risk-based Monitoring Software<\/a>, Risk-based Monitoring Software Industry Analysis<\/a>, Risk-based Monitoring Software Industry Forecast<\/a>, Risk-based Monitoring Software Industry Market<\/a>, Risk-based Monitoring Software Industry Segmentation<\/a>, Risk-based Monitoring Software Market<\/a>, Risk-based Monitoring Software Market Forecast<\/a>, Risk-based Monitoring Software Market Growth<\/a>, Risk-based Monitoring Software Market Players<\/a><\/p>\n Tags:<\/b> Mr. Ashish Mehra![\"™\"](\"https:\/\/s.w.org\/images\/core\/emoji\/11.2.0\/72x72\/2122.png\")
,<\/strong>the RBM software market is expected to reachUSD 511 million<\/span>by 2025 fromUSD 273 million<\/span>in 2020, at a CAGR of 13.3%.<\/p>\n
\nhttps:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=102112429<\/a><\/p>\n![\"risk-based-monitoring-software-market\"](\"https:\/\/pressrelease.icrowdnewswire.com\/assets\/source\/users\/1902\/risk-based-monitoring-software-market.jpg?1590409070595\")
<\/p>\n
\n<\/strong>30 – Figures
\n<\/strong>137 – Pages<\/strong><\/p>\nSee Campaign: <\/strong>https:\/\/www.marketsandmarkets.com\/Market-Reports\/risk-based-monitoring-software-market-102112429.htm<\/a>
Contact Information:<\/b>
Mr. Ashish Mehra
\nMarketsandMarkets INC.
\n630 Dundee Road
\nSuite 430
\nNorthbrook, IL 60062
\nUSA : 1-888-600-6441<\/p>\n
<\/a>, Extended Distribution<\/a>, Wire<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nMarketsandMarkets\u2122 INC.
\n630 Dundee Road
\nSuite 430
\nNorthbrook, IL 60062
\nUSA : 1-888-600-6441<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"According to the new market research report “Risk-based Monitoring Software Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) – Global Forecast to 2025“, published by MarketsandMarkets™, the RBM software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a … Continue reading Risk-based Monitoring Software Market Worth $511 Million by 2025 | Rising Number of Clinical Trials<\/span><\/a> Continue Reading